Please see internal notes.
"Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?"
"Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam
Amanda has 20 years research experience in the alcohol and other drug field. She has expertise in opioid overdose mortality and drug-related harms and is currently leading an NHMRC grant (APP1173505 $640K) investigating fatal and non-fatal overdose. She has an exceptional national and international reputation for her work on the changing nature of drug-related harms, particularly in relation to opioid-related deaths. Her work has directly influenced policy (regulatory decisions on pharmaceutical opioids) and she has provided expert advice to the Australian Government on opioid-related harms. Amanda also works with the Sydney Medically Supervised Injecting Centre (MSIC) analysing changes in service use and non-fatal overdose occurring onsite and has collaborated with the North Richmond Medically Supervised Injecting Room (MSIR).